With pharma and life sciences deal values surpassing $65 billion in Q1, marking the strongest quarter in the industry since ...

As it prepares to launch up to three new products from 2027 through 2028, Moderna is adjusting its way of doing business.  | ...

U.S. pharmaceutical lobby group PhRMA has launched a new ad offensive that looks to highlight the American life sciences ...

The United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) and the U.S. | The program looks to support ...

Recipharm has sketched out a “multi-million-dollar” investment in its U.S. manufacturing operations as part of a move to boost its sterile fill-finish capabilities and other production offerings for ...

With the passage of another year in the biz, and another slate of company earnings stacked up against one another, Fierce is ...

Stealth BioTherapeutics is looking to put its tumultuous path behind it with a new name. That new name is mighty—literally, as the biopharma is now Mighty Therapeutics, reflecting its recent change ...

DeepIntent has launched an agentic AI tool to help healthcare marketers more efficiently extract insights from databases ...

Merck & Co.’s first-in-class HIF-2 alpha inhibitor Welireg is touching down in the clear cell renal cell carcinoma (ccRCC) | ...

Following much opposition from drugmakers, Germany has scrapped its plan to install a program that would have reduced the ...

In patients with BTK-pretreated chronic lymphocytic leukemia (CLL), AbbVie and Roche’s Venclexta (venetoclax) is the drug to ...

IQVIA Digital has developed technology to help pharma marketers identify nurse practitioners (NPs) and physician associates ...